While the situation with the StageZero Life Sciences Ltd (OTCMKTS:SZLSF) stock was in the middle of a range on Tuesday, it should be noted that the company did make a major announcement yesterday.
On Tuesday, SZLSF stock ended flat at $0.2376 with more than 100 shares traded, compared to its average volume of 17k shares. The stock has moved within a range of $0.2376 – 0.2376 after opening trading at $0.2376.
Announces Formation of Scientific Advisory Board
Hence, it may be a good idea for investors to take a look at the announcement and make up their minds about the StageZero Life Sciences stock. The vertically integrated healthcare firm, which is involved in management and detection of conditions like cancer, announced yesterday that it had formed a new Scientific Advisory Board. The new board is made up of some of the leading experts in the field of metabolic pathway conditions.
The expertise of those who are part of the new Scientific Advisory Board spans across disciplines like metabolic conditions, oncology and nephrology. In this context, it is also important to point out that the new Scientific Advisory Board is going to be involved in evaluating the scientific and clinical initiatives of the company objectively. It goes without saying that the board is expected to perform a vital function for StageZero Life Sciences in the near term and it may be a good idea to keep an eye on its stock in the coming days.